Prosecution Insights
Last updated: November 04, 2026

Renmin Hospital Of Wuhan University

Technology area: Biotechnology & Pharmaceuticals

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Renmin Hospital Of Wuhan University is active in the Biotechnology & Pharmaceuticals technology area with 1 pending office action. This specific action represents the current state of the institution's patent prosecution. The presence of 1 pending office action suggests a concentrated effort to secure intellectual property rights within this technical domain.

The prosecution is managed through 1 distinct art unit and involves 1 distinct examiner. This concentration indicates that the hospital's current applications are being evaluated within a specific technical niche. For a practitioner, the involvement of 1 distinct examiner means that the prosecution strategy is not diversified across various perspectives at the patent office.

SITTON, JEHANNE SOUAYA is the busiest examiner for this portfolio, with a busiest examiner pending count of 1. This examiner is responsible for the 1 pending office action currently active. The success of the hospital's pending matters is therefore tied to the examination requirements of SITTON, JEHANNE SOUAYA. Practitioners should monitor the tendencies of SITTON, JEHANNE SOUAYA to anticipate the next steps in the prosecution process.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
0
Medium (0%)
1
Easy (100%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§112 only1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

1
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SITTON, JEHANNE SOUAYA 1 53.2% +47.5%

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18004030 METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA SITTON, JEHANNE SOUAYA 45d overdue

Top Art Units

Art UnitApps
1682 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18004030 METHYLATED MARKERS FOR ACCURATE DETECTION OF PRIMARY CENTRAL NERVOUS SYSTEM AND SYSTEMIC DIFFUSE LARGE B CELL LYMPHOMA SITTON, JEHANNE SOUAYA 1682 §112 Non-Final OA 45d overdue Pending Dec 30, 2022

Managing Renmin Hospital Of Wuhan University's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Renmin Hospital Of Wuhan University have?

Renmin Hospital Of Wuhan University has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.

Which USPTO examiner handles the most Renmin Hospital Of Wuhan University applications?

Jehanne Souaya Sitton has the most, with 1 of Renmin Hospital Of Wuhan University's pending office actions.

What technology area are Renmin Hospital Of Wuhan University's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month